Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus Compazine for Headache in the ED
NCT02657031Phase 4Completed
- Sponsor
- University Medical Center of Southern Nevada
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in Headache (2 arms), sponsored by University Medical Center of Southern Nevada. Primary endpoint: Headache Following Intervention. Started Mar 2016; status: completed.
02
Drugs
ketamine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT02657031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02657031.